High cholesterol is a common health condition that can lead to serious complications if left unmanaged. Fortunately, there are drinks to help manage it.

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the ...

The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

Report Ocean’s latest analysis delves into the “Vietnam Blood Glucose Monitoring Device Market” Report from 2024 to 2032, covering an array of market facets such as characteristics, size, growth, ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

A group of experts discusses the use of continuous glucose monitoring (CGM) technology in diabetes and its transformative ...

Prevent diabetes in the womb for a healthy future - insights from leading diabetologists on early intervention strategies.

The US Food and Drug Administration has cleared the latest version to last 5 days longer than previously for adult users.

The Food and Drug Administration has cleared diabetes-management firm DexCom's new continuous glucose monitoring (CGM) system ...

DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food ...

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship ...